Newsroom

Researchers have reported a new form of electronics known as 'drawn-on-skin electronics,' allowing multifunctional sensors and circuits to be drawn on the skin with an ink pen.

Building on early-stage funding by NIBIB to develop an implantable artificial kidney, researchers at the University of California San Francisco were selected for a substantial prize in the HHS KidneyX Challenge.

The National Institutes of Health awarded $248.7 million to seven companies to accelerate the development of new coronavirus diagnostic technologies as the country grapples with rising case numbers and testing shortages. The federal research agency expects some of the companies to potentially be able to perform hundreds of thousands of tests come September. Read more at Forbes.

he National Institutes of Health selected Ginkgo Bioworks, Mammoth Biosciences, Quidel, and four other companies to receive nearly $250 million to develop new Covid-19 diagnostic tests through its Rapid Acceleration of Diagnostics program, the agency announced Friday. Read more at STAT.

On Friday, the NIH announced the first seven winners of a competition to produce next-generation coronavirus tests to help battle the spread of COVID-19. Together, they will receive $248.7 million to further develop their tests and hopefully make them available by the fall. Read more at NPR.

NIH is investing $248.7 million in new technologies to address challenges associated with COVID-19 testing (which detects SARS-CoV-2 coronavirus). NIH’s RADx initiative has awarded contracts to seven biomedical diagnostic companies to support a range of new lab-based and point-of-care tests.

UCF Researchers were awarded a prize in the HHS KidneyX Challenge for development of an implantable artificial kidney device that allows patients to perform dialysis at home. The project previously received support from NIBIB.

Former NIBIB Director calls for collaboration among engineers and health professionals to address complicated challenges, including COVID19.

In a paper in the New England Journal of Medicine, scientific leaders from the National Institutes of Health set forth a framework to increase significantly the number, quality and type of daily tests for detecting SARS-CoV-2, the virus that causes COVID-19, and help reduce inequities for underserved populations that have been disproportionally affected by the disease.